RAPP — Rapport Therapeutics, Inc. Common Stock stock price, charts and financials

QT73Rapport Therapeutics, Inc. Common Stock

Rapport Therapeutics, Inc. Common Stock (NASDAQ: RAPP) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
40.45
-1.50-3.58%
OverviewShort InterestFilings
RAPPQT73Rapport Therapeutics, Inc. Common Stock·NASDAQ
40.45-3.58%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 09, 20264Statement of changes in beneficial ownership
Aug 26, 20264Statement of changes in beneficial ownership
Aug 26, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 20264Statement of changes in beneficial ownership
Aug 05, 202610-QQuarterly report
Aug 05, 20268-KCurrent report
Jul 29, 20264Statement of changes in beneficial ownership
Jul 15, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20268-KCurrent report
May 28, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 194
Page
▼
/ 8